Physician profile
Corey Forester
NPI 1508032459
$4,805.73
in general payments reported to CMS, 2019-2025
37 companies · $572 in 2025
The $572 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $244 · 2021: $622 · 2022: $1,076 · 2023: $1,063 · 2024: $914 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,455 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,454.61 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $657.89 | 2019-2023 | |
| Shield Therapeutics INC | $561.11 | 2023-2025 | Accrufer |
| Gynesonics, INC. | $400.96 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Aspira Women'S Health INC | $296.29 | 2021-2024 | Ova1 |
| Sumitomo Pharma America, INC. | $286.83 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $280.44 | 2019-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $265.87 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $249.44 | 2019-2025 | |
| Pfizer INC. | $240.65 | 2020-2024 | |
| Terumo Medical Corporation | $233.27 | 2019-2022 | |
| Exeltis, USA INC. | $201.26 | 2021-2025 | Slynd |
| Myovant Sciences INC. | $182.71 | 2021-2022 | |
| Avion Pharmaceuticals | $112.82 | 2020-2023 | Balcoltra |
| Channel Medsystems, INC. | $86.56 | 2023-2024 | |
| Organon LLC | $80.51 | 2021-2025 | Nexplanon |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $64.25 | 2022 | |
| Hologic Sales and Service, LLC | $63.43 | 2022-2025 | Aptima, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Millicent US INC | $62.79 | 2024-2025 | Femlyv, Intrarosa |
| Evofem Biosciences, INC. | $52.91 | 2021 | |
| Sage Therapeutics, LLC | $50.18 | 2024-2025 | Zurzuvae |
| Novo Nordisk INC | $47.80 | 2022 | |
| Amag Pharmaceuticals, INC. | $46.15 | 2019-2020 | |
| Agile Therapeutics, INC. | $35.79 | 2021 | |
| Amgen INC. | $28.88 | 2024 | Prolia, Evenity |
| Lupin INC. | $23.25 | 2019-2021 | |
| Daiichi Sankyo INC. | $21.64 | 2024 | Injectafer |
| Bard Peripheral Vascular, INC. | $20.34 | 2024 | Arista Ah Flexitip |
| Olympus America INC. | $19.65 | 2023 | Olympus, Endoeye Flex Deflectable Videoscope |
| Mylan Pharmaceuticals INC. | $19.61 | 2022 | |
| Coopersurgical, INC. | $17.23 | 2024 | Paragard T 380a |
| Therapeuticsmd, INC. | $16.45 | 2020 | |
| Scynexis, INC. | $15.72 | 2022 | |
| Duchesnay USA Incorporated | $15.01 | 2020 | |
| Davol INC. | $12.97 | 2023 | Arista Ah Flexitip |
| Allergan, INC. | $12.39 | 2020 | |
| Merck Sharp & Dohme LLC | $11.85 | 2020 | |
| Meditrina | $10.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Forester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.